Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus ...
Diversified Royalty is a TSX dividend stock that offers you a tasty payout in 2025. Is the TSX stock a good buy?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback